Jane Street Group, LLC Sellas Life Sciences Group, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.42 - $1.83 $15,665 - $20,188	11,032 New	11,032 $18,000
Q3 2021 Nov 16, 2021	BUY	$8.21 - $10.53 $167,213 - $214,464	20,367 New	20,367 $186,000
Q1 2021 May 18, 2021	SELL	$5.5 - $11.71 $106,496 - $226,740	-19,363 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$2.45 - $17.66 $47,439 - $341,950	19,363 New	19,363 $112,000

8.03M

2.52M

24.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.